Document Type: Original Article
Department of Pediatric Neurology, Ankara City Hospital, Ankara, Turkey
Department of Pediatric Neurology, Ondokuz Mayis University, Samsun, Turkey
Department of Pediatric Neurology, University of Health Sciences, Dr. Sami Ulus Research and Training Hospital, Ankara, Turkey
Department of Pediatric Neurology, WM Medical Park Pendik Hospital, Istanbul, Turkey
Background: The aim of this study was to identify the demographic-clinical variables affecting idiopathic epilepsy (IE) [called genetic generalized epilepsy (GGE)] recurrence and determine cut-off values that can be used in pediatric neurology practice for children with IE/GGE.
Methods: A total of 250 children and adolescents with IE/GGE were included and retrospectively evaluated. The patients’ hospital records were examined in order to identify possible electro-clinical features affecting epilepsy recurrence.
Results: The overall rate of recurrence in the patients was 46%; the age at onset of seizures in recurrence group was lower (P = 0.040) and the age at last seizure was higher in the recurrence group (P < 0.001) than that in the non-recurrence group. Other factors found to be related to recurrence were the shorter duration of the seizure-free period (P = 0.030), shorter interval between the last seizure and antiepileptic drug (AED) withdrawal (P = 0.003), shorter duration of AED withdrawal (P = 0.005), and the existence of abnormalities on sleep electroencephalogram (EEG) during AED withdrawal (P = 0.010) and at the 6th month of withdrawal (P < 0.001). According to receiver operating characteristic (ROC) analysis, the risk of IE recurrence was higher in children who were younger than 3.6 years old (sensitivity: 65.6%, specificity: 62.7%), children with a seizure-free period that was shorter than 35.5 months (sensitivity: 89.6%, specificity: 32.8%), and children whose drug withdrawal period was shorter than 4.5 months (sensitivity: 56.3%, specificity: 71.6%).
Conclusion: This study defined some electro-clinical factors that could guide clinicians when deciding to withdraw AEDs with regard to recurrence risk after evaluating a homogenous population of children with a diagnosis of IE/GGE.
- Proposal for revised classification of epilepsies and epileptic syndromes. Commission on classification and terminology of the international league against epilepsy. Epilepsia 1989; 30(4): 389-99.
- Bouma PA, Peters AC, Arts RJ, Stijnen T, Van Rossum J. Discontinuation of antiepileptic therapy: A prospective study in children. J Neurol Neurosurg Psychiatry 1987; 50(12): 1579-83.
- Gherpelli JL, Kok F, dal Forno S., Elkis LC, Lefevre BH, Diament AJ. Discontinuing medication in epileptic children: A study of risk factors related to recurrence. Epilepsia 1992; 33(4): 681-6.
- Verrotti A, Morresi S, Basciani F, Cutarella R, Morgese G, Chiarelli F. Discontinuation of anticonvulsant therapy in children with partial epilepsy. Neurology 2000; 55(9): 1393-5.
- Arts WF, Visser LH, Loonen MC, Tjiam AT, Stroink H, Stuurman PM, et al. Follow-up of 146 children with epilepsy after withdrawal of antiepileptic therapy. Epilepsia 1988; 29(3): 244-50.
- Matricardi M, Brinciotti M, Benedetti P. Outcome after discontinuation of antiepileptic drug therapy in children with epilepsy. Epilepsia 1989; 30(5): 582-9.
- Emerson R, D'Souza BJ, Vining EP, Holden KR, Mellits ED, Freeman JM. Stopping medication in children with epilepsy: Predictors of outcome. N Engl J Med 1981; 304(19): 1125-9.
- Murakami M, Konishi T, Naganuma Y, Hongou K, Yamatani M. Withdrawal of antiepileptic drug treatment in childhood epilepsy: Factors related to age. J Neurol Neurosurg Psychiatry 1995; 59(5): 477-81.
- Lamberink HJ, Otte WM, Geerts AT, Pavlovic M, Ramos-Lizana J, Marson AG, et al. Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: A systematic review and individual participant data meta-analysis. Lancet Neurol 2017; 16(7): 523-31.
- Andersson T, Braathen G, Persson A, Theorell K. A comparison between one and three years of treatment in uncomplicated childhood epilepsy: A prospective study. II. The EEG as predictor of outcome after withdrawal of treatment. Epilepsia 1997; 38(2): 225-32.
- Ramos-Lizana J, Aguirre-Rodriguez J, Aguilera-Lopez P, Cassinello-Garcia E. Recurrence risk after withdrawal of antiepileptic drugs in children with epilepsy: A prospective study. Eur J Paediatr Neurol 2010; 14(2): 116-24.
- Peters AC, Brouwer OF, Geerts AT, Arts WF, Stroink H, van Donselaar CA. Randomized prospective study of early discontinuation of antiepileptic drugs in children with epilepsy. Neurology 1998; 50(3): 724-30.
- Braathen G, Melander H. Early discontinuation of treatment in children with uncomplicated epilepsy: A prospective study with a model for prediction of outcome. Epilepsia 1997; 38(5): 561-9.
- Serra JG, Montenegro MA, Guerreiro MM. Antiepileptic drug withdrawal in childhood: Does the duration of tapering off matter for seizure recurrence? J Child Neurol 2005; 20(7): 624-6.
- Arts WF, Brouwer OF, Peters AC, Stroink H, Peeters EA, Schmitz PI, et al. Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood. Brain 2004; 127(Pt 8): 1774-84.
- Altunbasak S, Artar O, Burgut R, Yildiztas D. Relapse risk analysis after drug withdrawal in epileptic children with uncomplicated seizures. Seizure 1999; 8(7): 384-9.
- Olmez A, Arslan U, Turanli G, Aysun S. Risk of recurrence after drug withdrawal in childhood epilepsy. Seizure 2009; 18(4): 251-6.
- Sillanpaa M, Jalava M, Kaleva O, Shinnar S. Long-term prognosis of seizures with onset in childhood. N Engl J Med 1998; 338(24): 1715-22.
- Shinnar S, Vining EP, Mellits ED, D'Souza BJ, Holden K, Baumgardner RA, et al. Discontinuing antiepileptic medication in children with epilepsy after two years without seizures. A prospective study. N Engl J Med 1985; 313(16): 976-80.
- Hawash KY, Rosman NP. Do partial seizures predict an increased risk of seizure recurrence after antiepilepsy drugs are withdrawn? J Child Neurol 2003; 18(5): 331-7.